Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles-Reference-Cited by-同舟云学术

Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles

Published:2014-07 Issue:1 Volume:102 Page:99-102
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Reichman David E.,Zakarin Lauren,Chao Kenny,Meyer Laura,Davis Owen K.,Rosenwaks Zev

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference14 articles.

1. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial

2. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication

3. Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction;Ludwig;Arch Gynecol Obstet,2000

4. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group

5. The effect of an individualized GnRH antagonist protocol on folliculogenesis in IVF/ICSI;Mochtar;Hum Reprod,2004

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A modified flexible GnRH antagonist protocol using antagonist early cessation and a gonadotropin step-down approach improves live birth rates in fresh cycles: a randomized controlled trial;Human Reproduction;2024-06-28

2. Oral medroxyprogesterone acetate for the use of ovulation suppression in in vitro fertilization: a cohort trial;Fertility and Sterility;2024-05

3. Comparison of progestin‐primed ovarian stimulation regimen and antagonist regimen in women aged 35 years or older with diminished ovarian reserve: A propensity score‐matched study;International Journal of Gynecology & Obstetrics;2024-04-15

4. The use of progestins to prevent the LH surge in IVF cycles;Handbook of Current and Novel Protocols for the Treatment of Infertility;2024

5. The effects of flexible short protocol with gonadotropin-releasing hormone antagonist on preventing premature ovulation in poor responders;Archives of Gynecology and Obstetrics;2023-12-05